Dog Prescription Drugs Market
1 Study Coverage
1.1 Dog Prescription Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Dog Prescription Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Type
1.2.3 Smear Type
1.2.4 Injection Type
1.2.5 Spray Type
1.3 Market by Application
1.3.1 Global Dog Prescription Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dog Prescription Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Dog Prescription Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Dog Prescription Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dog Prescription Drugs Sales by Region
2.4.1 Global Dog Prescription Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Dog Prescription Drugs by Region (2023-2028)
2.5 Global Dog Prescription Drugs Revenue by Region
2.5.1 Global Dog Prescription Drugs Revenue by Region (2017-2022)
2.5.2 Global Dog Prescription Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dog Prescription Drugs Sales by Manufacturers
3.1.1 Global Top Dog Prescription Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Dog Prescription Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dog Prescription Drugs in 2021
3.2 Global Dog Prescription Drugs Revenue by Manufacturers
3.2.1 Global Dog Prescription Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Dog Prescription Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dog Prescription Drugs Revenue in 2021
3.3 Global Dog Prescription Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dog Prescription Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dog Prescription Drugs Sales by Type
4.1.1 Global Dog Prescription Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Dog Prescription Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Dog Prescription Drugs Sales Market Share by Type (2017-2028)
4.2 Global Dog Prescription Drugs Revenue by Type
4.2.1 Global Dog Prescription Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Dog Prescription Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Dog Prescription Drugs Price by Type
4.3.1 Global Dog Prescription Drugs Price by Type (2017-2022)
4.3.2 Global Dog Prescription Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dog Prescription Drugs Sales by Application
5.1.1 Global Dog Prescription Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Dog Prescription Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Dog Prescription Drugs Sales Market Share by Application (2017-2028)
5.2 Global Dog Prescription Drugs Revenue by Application
5.2.1 Global Dog Prescription Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Dog Prescription Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Dog Prescription Drugs Price by Application
5.3.1 Global Dog Prescription Drugs Price by Application (2017-2022)
5.3.2 Global Dog Prescription Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dog Prescription Drugs Market Size by Type
6.1.1 North America Dog Prescription Drugs Sales by Type (2017-2028)
6.1.2 North America Dog Prescription Drugs Revenue by Type (2017-2028)
6.2 North America Dog Prescription Drugs Market Size by Application
6.2.1 North America Dog Prescription Drugs Sales by Application (2017-2028)
6.2.2 North America Dog Prescription Drugs Revenue by Application (2017-2028)
6.3 North America Dog Prescription Drugs Market Size by Country
6.3.1 North America Dog Prescription Drugs Sales by Country (2017-2028)
6.3.2 North America Dog Prescription Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dog Prescription Drugs Market Size by Type
7.1.1 Europe Dog Prescription Drugs Sales by Type (2017-2028)
7.1.2 Europe Dog Prescription Drugs Revenue by Type (2017-2028)
7.2 Europe Dog Prescription Drugs Market Size by Application
7.2.1 Europe Dog Prescription Drugs Sales by Application (2017-2028)
7.2.2 Europe Dog Prescription Drugs Revenue by Application (2017-2028)
7.3 Europe Dog Prescription Drugs Market Size by Country
7.3.1 Europe Dog Prescription Drugs Sales by Country (2017-2028)
7.3.2 Europe Dog Prescription Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dog Prescription Drugs Market Size by Type
8.1.1 Asia Pacific Dog Prescription Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Dog Prescription Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Dog Prescription Drugs Market Size by Application
8.2.1 Asia Pacific Dog Prescription Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Dog Prescription Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Dog Prescription Drugs Market Size by Region
8.3.1 Asia Pacific Dog Prescription Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Dog Prescription Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dog Prescription Drugs Market Size by Type
9.1.1 Latin America Dog Prescription Drugs Sales by Type (2017-2028)
9.1.2 Latin America Dog Prescription Drugs Revenue by Type (2017-2028)
9.2 Latin America Dog Prescription Drugs Market Size by Application
9.2.1 Latin America Dog Prescription Drugs Sales by Application (2017-2028)
9.2.2 Latin America Dog Prescription Drugs Revenue by Application (2017-2028)
9.3 Latin America Dog Prescription Drugs Market Size by Country
9.3.1 Latin America Dog Prescription Drugs Sales by Country (2017-2028)
9.3.2 Latin America Dog Prescription Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dog Prescription Drugs Market Size by Type
10.1.1 Middle East and Africa Dog Prescription Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dog Prescription Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Dog Prescription Drugs Market Size by Application
10.2.1 Middle East and Africa Dog Prescription Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dog Prescription Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Dog Prescription Drugs Market Size by Country
10.3.1 Middle East and Africa Dog Prescription Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dog Prescription Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Corporation Information
11.1.2 Elanco Animal Health Overview
11.1.3 Elanco Animal Health Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Elanco Animal Health Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Elanco Animal Health Recent Developments
11.2 Ceva Sante Animale
11.2.1 Ceva Sante Animale Corporation Information
11.2.2 Ceva Sante Animale Overview
11.2.3 Ceva Sante Animale Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ceva Sante Animale Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ceva Sante Animale Recent Developments
11.3 MSD Animal Health
11.3.1 MSD Animal Health Corporation Information
11.3.2 MSD Animal Health Overview
11.3.3 MSD Animal Health Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MSD Animal Health Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MSD Animal Health Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zoetis Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoetis Recent Developments
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Overview
11.5.3 Virbac Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Virbac Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Dechra
11.6.1 Dechra Corporation Information
11.6.2 Dechra Overview
11.6.3 Dechra Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dechra Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dechra Recent Developments
11.7 Vetoquinol
11.7.1 Vetoquinol Corporation Information
11.7.2 Vetoquinol Overview
11.7.3 Vetoquinol Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Vetoquinol Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Vetoquinol Recent Developments
11.8 Animalcare Group
11.8.1 Animalcare Group Corporation Information
11.8.2 Animalcare Group Overview
11.8.3 Animalcare Group Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Animalcare Group Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Animalcare Group Recent Developments
11.9 Ourofino Saude Animal
11.9.1 Ourofino Saude Animal Corporation Information
11.9.2 Ourofino Saude Animal Overview
11.9.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ourofino Saude Animal Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ourofino Saude Animal Recent Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Corporation Information
11.10.2 Boehringer Ingelheim Overview
11.10.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Boehringer Ingelheim Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Boehringer Ingelheim Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dog Prescription Drugs Industry Chain Analysis
12.2 Dog Prescription Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dog Prescription Drugs Production Mode & Process
12.4 Dog Prescription Drugs Sales and Marketing
12.4.1 Dog Prescription Drugs Sales Channels
12.4.2 Dog Prescription Drugs Distributors
12.5 Dog Prescription Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dog Prescription Drugs Industry Trends
13.2 Dog Prescription Drugs Market Drivers
13.3 Dog Prescription Drugs Market Challenges
13.4 Dog Prescription Drugs Market Restraints
14 Key Findings in The Global Dog Prescription Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dog Prescription Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Type
Table 3. Major Manufacturers of Smear Type
Table 4. Major Manufacturers of Injection Type
Table 5. Major Manufacturers of Spray Type
Table 6. Global Dog Prescription Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Dog Prescription Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Dog Prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global Dog Prescription Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Dog Prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global Dog Prescription Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Dog Prescription Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Dog Prescription Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Dog Prescription Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Dog Prescription Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Dog Prescription Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Dog Prescription Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Dog Prescription Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Dog Prescription Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Dog Prescription Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Dog Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Prescription Drugs as of 2021)
Table 23. Dog Prescription Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dog Prescription Drugs Product Offered
Table 25. Date of Manufacturers Enter into Dog Prescription Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dog Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global Dog Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global Dog Prescription Drugs Sales Share by Type (2017-2022)
Table 30. Global Dog Prescription Drugs Sales Share by Type (2023-2028)
Table 31. Global Dog Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Dog Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Dog Prescription Drugs Revenue Share by Type (2017-2022)
Table 34. Global Dog Prescription Drugs Revenue Share by Type (2023-2028)
Table 35. Dog Prescription Drugs Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Dog Prescription Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Dog Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 38. Global Dog Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 39. Global Dog Prescription Drugs Sales Share by Application (2017-2022)
Table 40. Global Dog Prescription Drugs Sales Share by Application (2023-2028)
Table 41. Global Dog Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Dog Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Dog Prescription Drugs Revenue Share by Application (2017-2022)
Table 44. Global Dog Prescription Drugs Revenue Share by Application (2023-2028)
Table 45. Dog Prescription Drugs Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Dog Prescription Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Dog Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America Dog Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America Dog Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Dog Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Dog Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 52. North America Dog Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 53. North America Dog Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Dog Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Dog Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America Dog Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America Dog Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Dog Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Dog Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe Dog Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe Dog Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Dog Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Dog Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Europe Dog Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 65. Europe Dog Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Dog Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Dog Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe Dog Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe Dog Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Dog Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Dog Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Dog Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Dog Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Dog Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Dog Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Dog Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Dog Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Dog Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Dog Prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Dog Prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Dog Prescription Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Dog Prescription Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Dog Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Dog Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Dog Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Dog Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Dog Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Dog Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Dog Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Dog Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Dog Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Dog Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Dog Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Dog Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Dog Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Dog Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Dog Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Dog Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Dog Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Dog Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Dog Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Dog Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Dog Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Dog Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Dog Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Dog Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Elanco Animal Health Corporation Information
Table 108. Elanco Animal Health Description and Major Businesses
Table 109. Elanco Animal Health Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Elanco Animal Health Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Elanco Animal Health Recent Developments
Table 112. Ceva Sante Animale Corporation Information
Table 113. Ceva Sante Animale Description and Major Businesses
Table 114. Ceva Sante Animale Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Ceva Sante Animale Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Ceva Sante Animale Recent Developments
Table 117. MSD Animal Health Corporation Information
Table 118. MSD Animal Health Description and Major Businesses
Table 119. MSD Animal Health Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. MSD Animal Health Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. MSD Animal Health Recent Developments
Table 122. Zoetis Corporation Information
Table 123. Zoetis Description and Major Businesses
Table 124. Zoetis Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Zoetis Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Zoetis Recent Developments
Table 127. Virbac Corporation Information
Table 128. Virbac Description and Major Businesses
Table 129. Virbac Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Virbac Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Virbac Recent Developments
Table 132. Dechra Corporation Information
Table 133. Dechra Description and Major Businesses
Table 134. Dechra Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Dechra Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dechra Recent Developments
Table 137. Vetoquinol Corporation Information
Table 138. Vetoquinol Description and Major Businesses
Table 139. Vetoquinol Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Vetoquinol Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Vetoquinol Recent Developments
Table 142. Animalcare Group Corporation Information
Table 143. Animalcare Group Description and Major Businesses
Table 144. Animalcare Group Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Animalcare Group Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Animalcare Group Recent Developments
Table 147. Ourofino Saude Animal Corporation Information
Table 148. Ourofino Saude Animal Description and Major Businesses
Table 149. Ourofino Saude Animal Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Ourofino Saude Animal Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ourofino Saude Animal Recent Developments
Table 152. Boehringer Ingelheim Corporation Information
Table 153. Boehringer Ingelheim Description and Major Businesses
Table 154. Boehringer Ingelheim Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Boehringer Ingelheim Dog Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Boehringer Ingelheim Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Dog Prescription Drugs Distributors List
Table 160. Dog Prescription Drugs Customers List
Table 161. Dog Prescription Drugs Market Trends
Table 162. Dog Prescription Drugs Market Drivers
Table 163. Dog Prescription Drugs Market Challenges
Table 164. Dog Prescription Drugs Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Prescription Drugs Product Picture
Figure 3. Global Dog Prescription Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Type Product Picture
Figure 4. Smear Type Product Picture
Figure 5. Injection Type Product Picture
Figure 6. Spray Type Product Picture
Figure 7. Global Dog Prescription Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dog Prescription Drugs Report Years Considered
Figure 12. Global Dog Prescription Drugs Sales 2017-2028 (K Units)
Figure 13. Global Dog Prescription Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Dog Prescription Drugs Revenue 2017-2028 (US$ Million)
Figure 15. Global Dog Prescription Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Dog Prescription Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Dog Prescription Drugs Sales Market Share by Region (2023-2028)
Figure 18. North America Dog Prescription Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. North America Dog Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Dog Prescription Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Dog Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Dog Prescription Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Dog Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Dog Prescription Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Dog Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Dog Prescription Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Dog Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Dog Prescription Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Dog Prescription Drugs in the World: Market Share by Dog Prescription Drugs Revenue in 2021
Figure 30. Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Dog Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Dog Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 35. North America Dog Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 37. North America Dog Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 39. North America Dog Prescription Drugs Sales Share by Country (2017-2028)
Figure 40. North America Dog Prescription Drugs Revenue Share by Country (2017-2028)
Figure 41. U.S. Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Dog Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 45. Europe Dog Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 47. Europe Dog Prescription Drugs Sales Share by Country (2017-2028)
Figure 48. Europe Dog Prescription Drugs Revenue Share by Country (2017-2028)
Figure 49. Germany Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. France Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Dog Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Dog Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Dog Prescription Drugs Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Dog Prescription Drugs Revenue Share by Region (2017-2028)
Figure 60. China Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. India Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Dog Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 71. Latin America Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Dog Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 73. Latin America Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Dog Prescription Drugs Sales Share by Country (2017-2028)
Figure 75. Latin America Dog Prescription Drugs Revenue Share by Country (2017-2028)
Figure 76. Mexico Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Dog Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Dog Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Dog Prescription Drugs Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Dog Prescription Drugs Revenue Share by Country (2017-2028)
Figure 85. Turkey Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Dog Prescription Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. Dog Prescription Drugs Value Chain
Figure 89. Dog Prescription Drugs Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
